Bio Impact Capital LLC Context Therapeutics Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 14,705,882 shares of CNTX stock, worth $12.6 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
14,705,882Holding current value
$12.6 Million% of portfolio
2.18%Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX7.48MShares$6.43 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.38 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.38 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.47 Million2.69% of portfolio
-
Great Point Partners LLC Greenwich, CT4.68MShares$4.03 Million3.06% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $13.7M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...